Page last updated: 2024-09-02

carboxyamido-triazole and cyclic gmp

carboxyamido-triazole has been researched along with cyclic gmp in 1 studies

Compound Research Comparison

Studies
(carboxyamido-triazole)
Trials
(carboxyamido-triazole)
Recent Studies (post-2010)
(carboxyamido-triazole)
Studies
(cyclic gmp)
Trials
(cyclic gmp)
Recent Studies (post-2010) (cyclic gmp)
105152222,3463334,062

Protein Interaction Comparison

ProteinTaxonomycarboxyamido-triazole (IC50)cyclic gmp (IC50)
Phosphodiesterase Bos taurus (cattle)0.1
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)2.4
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)2.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, C; Guo, L; Ju, R; Li, J; Luo, L; Ye, C; Yu, X; Zhang, D; Zhu, L1

Other Studies

1 other study(ies) available for carboxyamido-triazole and cyclic gmp

ArticleYear
Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases.
    European journal of pharmacology, 2015, Jan-05, Volume: 746

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Line, Tumor; Cyclic AMP; Cyclic GMP; Intracellular Space; Male; Mice; Phosphodiesterase Inhibitors; Rats; Signal Transduction; Triazoles

2015